News Archives - Page 65 of 136 - MassBio

News

CMS Proposes to Repeal Device Coverage Pathway and “Reasonable and Necessary” Regulations

Nov 08, 2021

Posted by Sidley Austin

News

Pharmacovigilance Considerations in the Era of Patient Centricity: Data Collected by Apps

Nov 08, 2021

Posted by Sidley Austin

News

The Lessons of In Re: Boeing for Healthcare and Life Sciences Companies

Nov 08, 2021

Posted by Sidley Austin

News

Avid Bioservices Announces Expansion into Viral Vector Development and Manufacturing Services for Cell and Gene Therapy

Nov 04, 2021

Posted by Avid Bioservices, Inc.

News

EdiGene to Present Latest Research on A Novel Surface Marker and Migration of Hematopoietic Stem Cell (HSC)

Nov 04, 2021

News

Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 1 Dose Expansion Study of TP-1287 in Patients with Sarcoma

Nov 03, 2021

Posted by Sumitomo Pharma Oncology, Inc.

News

eClinical Solutions Enhances elluminate Clinical Data Cloud with RBQM

Nov 03, 2021

News

Diversity of Investigative Site Staff Highly Associated with the Diversity of Patients Enrolled in Clinical Trials, According to Tufts Center for the Study of Drug Development

Nov 03, 2021

Posted by Tufts University

News

EdiGene Secures New Lab and Office Space for Its Growing U.S. R&D Center to Advance Gene-editing Based Therapies

Nov 02, 2021

News

CLA Supports M2D2 and the Massachusetts Life Sciences Ecosystem

Nov 01, 2021

News

Greenberg Traurig Continues IP and Life Sciences Growth in Boston

Oct 27, 2021

Posted by Greenberg Traurig, LLP

News

Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 1 Study of DSP-0390 in Patients with Recurrent High-Grade Glioma

Oct 26, 2021

Posted by Sumitomo Pharma Oncology, Inc.